These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20686344)

  • 1. 5-aminoimidazole-4-carboxamide-1-beta-ribofuranoside (AICAR) prevents nuclear translocation of constitutive androstane receptor by AMP-activated protein kinase (AMPK) independent manner.
    Kanno Y; Inoue Y; Inouye Y
    J Toxicol Sci; 2010 Aug; 35(4):571-6. PubMed ID: 20686344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMP-activated protein kinase mediates phenobarbital induction of CYP2B gene expression in hepatocytes and a newly derived human hepatoma cell line.
    Rencurel F; Stenhouse A; Hawley SA; Friedberg T; Hardie DG; Sutherland C; Wolf CR
    J Biol Chem; 2005 Feb; 280(6):4367-73. PubMed ID: 15572372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver.
    Rencurel F; Foretz M; Kaufmann MR; Stroka D; Looser R; Leclerc I; da Silva Xavier G; Rutter GA; Viollet B; Meyer UA
    Mol Pharmacol; 2006 Dec; 70(6):1925-34. PubMed ID: 16988011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A physiological role of AMP-activated protein kinase in phenobarbital-mediated constitutive androstane receptor activation and CYP2B induction.
    Shindo S; Numazawa S; Yoshida T
    Biochem J; 2007 Feb; 401(3):735-41. PubMed ID: 17032173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
    Mukhtar MH; Payne VA; Arden C; Harbottle A; Khan S; Lange AJ; Agius L
    Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R766-74. PubMed ID: 18199594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
    Zhuge J
    Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation.
    Guigas B; Bertrand L; Taleux N; Foretz M; Wiernsperger N; Vertommen D; Andreelli F; Viollet B; Hue L
    Diabetes; 2006 Apr; 55(4):865-74. PubMed ID: 16567505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase.
    Giri S; Nath N; Smith B; Viollet B; Singh AK; Singh I
    J Neurosci; 2004 Jan; 24(2):479-87. PubMed ID: 14724246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.
    Hasenour CM; Ridley DE; Hughey CC; James FD; Donahue EP; Shearer J; Viollet B; Foretz M; Wasserman DH
    J Biol Chem; 2014 Feb; 289(9):5950-9. PubMed ID: 24403081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion.
    Bradley EA; Eringa EC; Stehouwer CD; Korstjens I; van Nieuw Amerongen GP; Musters R; Sipkema P; Clark MG; Rattigan S
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1137-42. PubMed ID: 20224051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside reduces glucose uptake via the inhibition of Na+/H+ exchanger 1 in isolated rat ventricular cardiomyocytes.
    Ségalen C; Longnus SL; Baetz D; Counillon L; Van Obberghen E
    Endocrinology; 2008 Apr; 149(4):1490-8. PubMed ID: 18187546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
    Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY
    Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMP-activated protein kinase (AMPK) activation inhibits nuclear translocation of Smad4 in mesangial cells and diabetic kidneys.
    Zhao J; Miyamoto S; You YH; Sharma K
    Am J Physiol Renal Physiol; 2015 May; 308(10):F1167-77. PubMed ID: 25428125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions.
    Langelueddecke C; Jakab M; Ketterl N; Lehner L; Hufnagl C; Schmidt S; Geibel JP; Fuerst J; Ritter M
    Cell Physiol Biochem; 2012; 29(1-2):75-86. PubMed ID: 22415077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR.
    Russell RR; Bergeron R; Shulman GI; Young LH
    Am J Physiol; 1999 Aug; 277(2):H643-9. PubMed ID: 10444490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AICAR inhibits NFκB DNA binding independently of AMPK to attenuate LPS-triggered inflammatory responses in human macrophages.
    Kirchner J; Brüne B; Namgaladze D
    Sci Rep; 2018 May; 8(1):7801. PubMed ID: 29773845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMP-activated protein kinase activation by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) inhibits palmitate-induced endothelial cell apoptosis through reactive oxygen species suppression.
    Kim JE; Kim YW; Lee IK; Kim JY; Kang YJ; Park SY
    J Pharmacol Sci; 2008 Mar; 106(3):394-403. PubMed ID: 18360094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
    Suwa M; Nakano H; Radak Z; Kumagai S
    Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase.
    Holmes BF; Sparling DP; Olson AL; Winder WW; Dohm GL
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1071-6. PubMed ID: 16105857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of AMP-activated protein kinase stimulates the nuclear localization of glyceraldehyde 3-phosphate dehydrogenase in human diploid fibroblasts.
    Kwon HJ; Rhim JH; Jang IS; Kim GE; Park SC; Yeo EJ
    Exp Mol Med; 2010 Apr; 42(4):254-69. PubMed ID: 20177150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.